|
Prescription and Over-the-Counter Drug Product List
27th Edition
Cumulative Supplement Number 4: April 2007
NOTE: The format for the Monthly Additions/Deletions Drug
Product List changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.6
Cumulative Supplement Legend.
ALENDRONATE SODIUM; CHOLECALCIFEROL
TABLET; ORAL
FOSAMAX PLUS D
>D> + MERCK EQ 70MG BASE;2,800 IU N21762 001 Apr 07, 2005 Apr CRLD
>A> EQ 70MG BASE;2,800 IU N21762 001 Apr 07, 2005 Apr CRLD
>A> + EQ 70MG BASE;5,600 IU N21762 002 Apr 26, 2007 Apr NEWA
ALPROSTADIL
INJECTABLE; INJECTION
>D> CAVERJECT
>D> PHARMACIA AND 0.01MG/VIAL N21212 001 Jun 11, 2002 Apr CTNA
>D> 0.02MG/VIAL N21212 002 Jun 11, 2002 Apr CTNA
>A> CAVERJECT IMPULSE
>A> PHARMACIA AND 0.01MG/VIAL N21212 001 Jun 11, 2002 Apr CTNA
>A> 0.02MG/VIAL N21212 002 Jun 11, 2002 Apr CTNA
ARIPIPRAZOLE
SOLUTION; ORAL
ABILIFY
>D> + OTSUKA 1MG/ML N21713 001 Dec 10, 2004 Apr CAHN
>A> + OTSUKA PHARM 1MG/ML N21713 001 Dec 10, 2004 Apr CAHN
AZITHROMYCIN
>A> SOLUTION/DROPS; OPHTHALMIC
>A> AZASITE
>A> + INSITE VISION 1% N50810 001 Apr 27, 2007 Apr NEWA
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
GEL; TOPICAL
BENZACLIN
>A> @ SANOFI AVENTIS US 5%;EQ 1% BASE N50756 002 Apr 20, 2007 Apr DISC
BENZPHETAMINE HYDROCHLORIDE
TABLET; ORAL
BENZPHETAMINE HYDROCHLORIDE
>A> AA TYCO HLTHCARE 50MG N40773 001 Apr 25, 2007 Apr NEWA
BETAINE HYDROCHLORIDE
FOR SOLUTION; ORAL
CYSTADANE
>D> + JAZZ 1GM/SCOOPFUL N20576 001 Oct 25, 1996 Apr CAHN
>A> + RARE DIS 1GM/SCOOPFUL N20576 001 Oct 25, 1996 Apr CAHN
CARBIDOPA; ENTACAPONE; LEVODOPA
TABLET; ORAL
STALEVO 50
>D> ORION PHARMA INC 12.5MG;200MG;50MG N21485 001 Jun 11, 2003 Apr CRLD
>A> + 12.5MG;200MG;50MG N21485 001 Jun 11, 2003 Apr CRLD
CARBOPLATIN
INJECTABLE; IV (INFUSION)
CARBOPLATIN
>A> AP GENERAMEDIX EQ 50MG/5ML (10MG/ML) N77998 001 Apr 24, 2007 Apr NEWA
>A> AP EQ 150MG/ML (10MG/ML) N77998 002 Apr 24, 2007 Apr NEWA
>A> AP EQ 450MG/45ML (10MG/ML) N77998 003 Apr 24, 2007 Apr NEWA
CEFACLOR
CAPSULE; ORAL
CEFACLOR
>D> AB CEPH INTL EQ 250MG BASE N62205 001 Apr DISC
>A> @ EQ 250MG BASE N62205 001 Apr DISC
>D> AB EQ 500MG BASE N62205 002 Apr DISC
>A> @ EQ 500MG BASE N62205 002 Apr DISC
CEFDINIR
FOR SUSPENSION; ORAL
CEFDINIR
>A> AB LUPIN 250MG/5ML N65259 002 May 07, 2007 Apr NEWA
>A> AB TEVA PHARMS 125MG/5ML N65332 001 May 04, 2007 Apr NEWA
>A> AB 250MG/5ML N65332 002 May 04, 2007 Apr NEWA
CEFIXIME
SUSPENSION; ORAL
CEFIXIME
>D> LUPIN PHARMS 200MG/5ML N65355 001 Apr 10, 2007 Apr CRLD
SUPRAX
>D> + LUPIN 100MG/5ML N65129 001 Feb 23, 2004 Apr CRLD
>A> LUPIN PHARMS 100MG/5ML N65129 001 Feb 23, 2004 Apr CRLD
>A> + 200MG/5ML N65355 001 Apr 10, 2007 Apr CRLD
CEFTRIAXONE SODIUM
INJECTABLE; IM-IV
>A> CEFTRIAXONE
>A> AP TEVA EQ 1GM BASE/VIAL N65262 001 Jun 29, 2006 Apr CTNA
>A> AP EQ 2GM BASE/VIAL N65262 002 Jun 29, 2006 Apr CTNA
>A> AP WOCKHARDT EQ 250MG BASE/VIAL N65391 001 Apr 12, 2007 Apr NEWA
>A> AP EQ 500MG BASE/VIAL N65391 002 Apr 12, 2007 Apr NEWA
>A> AP EQ 2GM BASE/VIAL N65391 003 Apr 12, 2007 Apr NEWA
>D> CEFTRIAXONE SODIUM
>D> AP TEVA EQ 1GM BASE/VIAL N65262 001 Jun 29, 2006 Apr CTNA
>D> AP EQ 2GM BASE/VIAL N65262 002 Jun 29, 2006 Apr CTNA
CIPROFLOXACIN HYDROCHLORIDE
TABLET; ORAL
CIPROFLOXACIN
>A> AB AUROBINDO EQ 250MG BASE N77859 001 Apr 26, 2007 Apr NEWA
>A> AB EQ 500MG BASE N77859 002 Apr 26, 2007 Apr NEWA
>A> AB EQ 750MG BASE N77859 003 Apr 26, 2007 Apr NEWA
CORTISONE ACETATE
INJECTABLE; INJECTION
CORTISONE ACETATE
>D> @ PHARMACIA AND 25MG/ML N08126 002 Apr DISC
>A> @ 25MG/ML N08126 002 Apr DISC
TABLET; ORAL
CORTISONE ACETATE
>D> PHARMACIA AND 5MG N08126 003 Apr DISC
>A> @ 5MG N08126 003 Apr DISC
>D> 10MG N08126 004 Apr DISC
>A> @ 10MG N08126 004 Apr DISC
>D> BP + 25MG N08126 001 Apr DISC
>A> @ 25MG N08126 001 Apr DISC
>D> BP WEST WARD 25MG N80776 002 Apr CRLD
>A> + 25MG N80776 002 Apr CRLD
DANAZOL
CAPSULE; ORAL
DANAZOL
>D> BARR 50MG N74582 003 May 29, 1998 Apr CTEC
>A> AB 50MG N74582 003 May 29, 1998 Apr CTEC
>D> 100MG N74582 002 May 29, 1998 Apr CTEC
>A> AB 100MG N74582 002 May 29, 1998 Apr CTEC
>A> AB LANNETT 50MG N78214 001 Apr 19, 2007 Apr NEWA
>A> AB 100MG N78214 002 Apr 19, 2007 Apr NEWA
DESMOPRESSIN ACETATE
SPRAY, METERED; NASAL
STIMATE
>A> + CSL BEHRING 0.15MG/SPRAY N20355 001 Mar 07, 1994 Apr CAHN
>D> + ZLB BEHRING 0.15MG/SPRAY N20355 001 Mar 07, 1994 Apr CAHN
DOXORUBICIN HYDROCHLORIDE
INJECTABLE; INJECTION
DOXORUBICIN HYDROCHLORIDE
>D> AP BEDFORD 10MG/VIAL N62921 001 Mar 17, 1989 Apr CRLD
>A> AP + 10MG/VIAL N62921 001 Mar 17, 1989 Apr CRLD
>D> AP 20MG/VIAL N62921 002 Mar 17, 1989 Apr CRLD
>A> AP + 20MG/VIAL N62921 002 Mar 17, 1989 Apr CRLD
>D> AP 50MG/VIAL N62921 003 Mar 17, 1989 Apr CRLD
>A> AP + 50MG/VIAL N62921 003 Mar 17, 1989 Apr CRLD
EPIRUBICIN HYDROCHLORIDE
INJECTABLE; INJECTION
ELLENCE
>D> + PFIZER INC 2MG/ML N50778 001 Sep 15, 1999 Apr CFTG
>A> AP + 2MG/ML (200MG/100ML) N50778 001 Sep 15, 1999 Apr CFTG
>A> AP 2MG/ML (50MG/25ML) N50778 002 Sep 15, 1999 Apr CFTG
EPIRUBICIN HYDROCHLORIDE
>A> HOSPIRA 2MG/ML (10MG/5ML) N65343 001 Apr 19, 2007 Apr NEWA
>A> AP 2MG/ML (50MG/25ML) N65343 002 Apr 19, 2007 Apr NEWA
>A> 2MG/ML (150MG/75ML) N65343 003 Apr 19, 2007 Apr NEWA
>A> AP 2MG/ML (200MG/100ML) N65343 004 Apr 19, 2007 Apr NEWA
ESTAZOLAM
TABLET; ORAL
>D> PROSOM
>D> AB ABBOTT 1MG N19080 001 Dec 26, 1990 Apr DISC
>A> @ 1MG N19080 001 Dec 26, 1990 Apr DISC
>D> AB + 2MG N19080 002 Dec 26, 1990 Apr DISC
>A> @ 2MG N19080 002 Dec 26, 1990 Apr DISC
ESTROGENS, CONJUGATED SYNTHETIC B
TABLET; ORAL
ENJUVIA
>A> DURAMED 0.9MG N21443 005 Apr 27, 2007 Apr NEWA
ETHINYL ESTRADIOL; LEVONORGESTREL
TABLET; ORAL-28
LEVONORGESTREL AND ETHINYL ESTRADIOL
>D> AB1 WATSON LABS 0.02MG;0.1MG N76625 001 Nov 18, 2004 Apr CRLD
>A> AB1 + 0.02MG;0.1MG N76625 001 Nov 18, 2004 Apr CRLD
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
TABLET; ORAL-28
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
>D> AB ANDRX PHARMS 0.02MG;1MG N77077 001 May 20, 2005 Apr CAHN
>D> AB 0.03MG;1.5MG N77075 001 Apr 28, 2005 Apr CAHN
>A> AB TEVA PHARMS 0.02MG;1MG N77077 001 May 20, 2005 Apr CAHN
>A> AB 0.03MG;1.5MG N77075 001 Apr 28, 2005 Apr CAHN
ETHINYL ESTRADIOL; NORGESTIMATE
TABLET; ORAL-28
PREVIFEM
>D> AB ANDRX PHARMS 0.035MG;0.25MG N76334 001 Jan 09, 2004 Apr CAHN
>A> AB TEVA PHARMS 0.035MG;0.25MG N76334 001 Jan 09, 2004 Apr CAHN
TRI-PREVIFEM
>D> AB ANDRX PHARMS 0.035MG,0.035MG,0.035MG;0.18MG,0. N76335 001 Mar 26, 2004 Apr CAHN
>D> AB 0.035MG,0.035MG,0.035MG;0.18MG,0. N76335 001 Mar 26, 2004 Apr CAHN
>D> AB 0.035MG,0.035MG,0.035MG;0.18MG,0. N76335 001 Mar 26, 2004 Apr CAHN
>A> AB TEVA PHARMS 0.035MG,0.035MG,0.035MG;0.18MG,0. N76335 001 Mar 26, 2004 Apr CAHN
>A> AB 0.035MG,0.035MG,0.035MG;0.18MG,0. N76335 001 Mar 26, 2004 Apr CAHN
>A> AB 0.035MG,0.035MG,0.035MG;0.18MG,0. N76335 001 Mar 26, 2004 Apr CAHN
ETODOLAC
CAPSULE; ORAL
ETODOLAC
>D> AB AAIPHARMA LLC 300MG N74929 001 Jan 30, 1998 Apr DISC
>A> @ 300MG N74929 001 Jan 30, 1998 Apr DISC
>D> AB GENPHARM 200MG N75071 001 Sep 30, 1998 Apr DISC
>A> @ 200MG N75071 001 Sep 30, 1998 Apr DISC
>D> AB 300MG N75071 002 Sep 30, 1998 Apr DISC
>A> @ 300MG N75071 002 Sep 30, 1998 Apr DISC
>D> AB MYLAN 200MG N74932 001 May 16, 1997 Apr DISC
>A> @ 200MG N74932 001 May 16, 1997 Apr DISC
>D> AB 300MG N74932 002 May 16, 1997 Apr DISC
>A> @ 300MG N74932 002 May 16, 1997 Apr DISC
>D> AB SANDOZ 200MG N74942 001 Sep 30, 1997 Apr DISC
>A> @ 200MG N74942 001 Sep 30, 1997 Apr DISC
>D> AB 200MG N74840 001 Aug 29, 1997 Apr DISC
>A> @ 200MG N74840 001 Aug 29, 1997 Apr DISC
>D> AB 300MG N74942 002 Sep 30, 1997 Apr DISC
>A> @ 300MG N74942 002 Sep 30, 1997 Apr DISC
>D> AB 300MG N74840 002 Aug 29, 1997 Apr DISC
>A> @ 300MG N74840 002 Aug 29, 1997 Apr DISC
>D> AB TEVA 200MG N75126 001 Sep 16, 1999 Apr DISC
>A> @ 200MG N75126 001 Sep 16, 1999 Apr DISC
>D> AB WATSON LABS 200MG N74844 001 Dec 23, 1997 Apr DISC
>A> @ 200MG N74844 001 Dec 23, 1997 Apr DISC
>D> AB 300MG N74844 002 Dec 23, 1997 Apr DISC
>A> @ 300MG N74844 002 Dec 23, 1997 Apr DISC
TABLET, EXTENDED RELEASE; ORAL
ETODOLAC
>D> AB ANDRX PHARMS 400MG N75829 001 Nov 30, 2001 Apr DISC
>A> @ 400MG N75829 001 Nov 30, 2001 Apr DISC
>D> AB 500MG N75829 002 Nov 30, 2001 Apr DISC
>A> @ 500MG N75829 002 Nov 30, 2001 Apr DISC
>D> AB SANDOZ 400MG N75943 001 Jul 26, 2002 Apr DISC
>A> @ 400MG N75943 001 Jul 26, 2002 Apr DISC
>D> AB 500MG N75943 002 Jul 26, 2002 Apr DISC
>A> @ 500MG N75943 002 Jul 26, 2002 Apr DISC
>D> AB 600MG N75943 003 Jul 26, 2002 Apr DISC
>A> @ 600MG N75943 003 Jul 26, 2002 Apr DISC
TABLET; ORAL
ETODOLAC
>D> AB AAIPHARMA LLC 400MG N74927 001 Oct 30, 1997 Apr DISC
>A> @ 400MG N74927 001 Oct 30, 1997 Apr DISC
>D> AB GENPHARM 400MG N75012 001 Sep 30, 1998 Apr DISC
>A> @ 400MG N75012 001 Sep 30, 1998 Apr DISC
>D> AB 500MG N75012 002 Sep 30, 1998 Apr DISC
>A> @ 500MG N75012 002 Sep 30, 1998 Apr DISC
>D> AB IVAX PHARMS 400MG N74883 001 Feb 28, 1997 Apr DISC
>A> @ 400MG N74883 001 Feb 28, 1997 Apr DISC
>D> AB 500MG N74883 002 Nov 20, 1998 Apr DISC
>A> @ 500MG N74883 002 Nov 20, 1998 Apr DISC
>D> AB RANBAXY 400MG N75226 001 Nov 24, 1998 Apr DISC
>A> @ 400MG N75226 001 Nov 24, 1998 Apr DISC
>D> AB 500MG N75226 002 Nov 24, 1998 Apr DISC
>A> @ 500MG N75226 002 Nov 24, 1998 Apr DISC
>D> AB SANDOZ 400MG N74846 001 Feb 28, 1997 Apr DISC
>A> @ 400MG N74846 001 Feb 28, 1997 Apr DISC
>D> AB 400MG N74839 001 Jul 11, 1997 Apr DISC
>A> @ 400MG N74839 001 Jul 11, 1997 Apr DISC
>D> AB TEVA 400MG N74847 001 Apr 23, 1999 Apr DISC
>A> @ 400MG N74847 001 Apr 23, 1999 Apr DISC
>D> AB 500MG N74847 002 Apr 23, 1999 Apr DISC
>A> @ 500MG N74847 002 Apr 23, 1999 Apr DISC
>D> AB WATSON LABS 400MG N75069 001 Apr 16, 1998 Apr DISC
>A> @ 400MG N75069 001 Apr 16, 1998 Apr DISC
>D> AB 400MG N74892 001 Apr 16, 1997 Apr DISC
>A> @ 400MG N74892 001 Apr 16, 1997 Apr DISC
>D> AB 500MG N74892 002 Oct 29, 1998 Apr DISC
>A> @ 500MG N74892 002 Oct 29, 1998 Apr DISC
FEXOFENADINE HYDROCHLORIDE
TABLET; ORAL
FEXOFENADINE HYDROCHLORIDE
>A> AB MYLAN 180MG N77081 001 Apr 16, 2007 Apr NEWA
FLUOROURACIL
INJECTABLE; INJECTION
FLUOROURACIL
>D> AP + ABRAXIS PHARM 50MG/ML N40379 001 Nov 15, 2000 Apr DISC
>A> @ 50MG/ML N40379 001 Nov 15, 2000 Apr DISC
>D> AP + 50MG/ML N40291 001 Mar 24, 1999 Apr DISC
>A> @ 50MG/ML N40291 001 Mar 24, 1999 Apr DISC
>A> AP + 500MG/10ML (50MG/ML) N40279 002 Sep 30, 1998 Apr NEWA
>D> AP + 50MG/ML N40279 001 Sep 30, 1998 Apr CPOT
>A> AP + 1GM/20ML (50MG/ML) N40279 001 Sep 30, 1998 Apr CPOT
>D> AP + 50MG/ML N40278 001 Sep 30, 1998 Apr CPOT
>A> AP + 2.5GM/50ML (50MG/ML) N40278 001 Sep 30, 1998 Apr CPOT
>A> AP + 5GM/100ML (50MG/ML) N40278 002 Sep 30, 1998 Apr NEWA
>A> AP + GENERAMEDIX 500MG/10ML (50MG/ML) N40743 002 Apr 26, 2007 Apr NEWA
>A> AP + 1GM/20ML (50MG/ML) N40743 001 Apr 26, 2007 Apr NEWA
>A> AP + 2.5GM/50ML (50MG/ML) N40798 002 Apr 26, 2007 Apr NEWA
>A> AP + 5GM/100ML (50MG/ML) N40798 001 Apr 26, 2007 Apr NEWA
>D> AP + SICOR PHARMS 50MG/ML N40333 001 Jan 27, 2000 Apr CPOT
>A> AP + 500MG/10ML (50MG/ML) N40333 001 Jan 27, 2000 Apr CPOT
>D> AP + 50MG/ML N40334 001 Feb 25, 2000 Apr CPOT
>A> AP + 2.5GM/50ML (50MG/ML) N40334 001 Feb 25, 2000 Apr CPOT
>A> AP + 5GM/100ML (50MG/ML) N40334 002 Feb 25, 2000 Apr NEWA
>D> AP + VALEANT 50MG/ML N12209 001 Apr CPOT
>A> AP + 500MG/10ML (50MG/ML) N12209 001 Apr CPOT
FLUOXETINE HYDROCHLORIDE; OLANZAPINE
CAPSULE; ORAL
SYMBYAX
>A> LILLY EQ 25MG BASE;EQ 3MG BASE N21520 001 Apr NEWA
FLURBIPROFEN
TABLET; ORAL
FLURBIPROFEN
>A> AB THERAGEN 100MG N74560 002 May 16, 1997 Apr CAHN
>D> AB WARNER CHILCOTT 100MG N74560 002 May 16, 1997 Apr CAHN
>A> FLUTICASONE FUROATE
>A> SPRAY, METERED; NASAL
>A> VERAMYST
>A> + GLAXOSMITHKLINE 0.0275MG/INH N22051 001 Apr 27, 2007 Apr NEWA
GLIPIZIDE; METFORMIN HYDROCHLORIDE
TABLET; ORAL
GLIPIZIDE AND METFORMIN HYDROCHLORIDE
>A> AB MYLAN 2.5MG;250MG N78083 001 Apr 12, 2007 Apr NEWA
>A> AB 2.5MG;500MG N78083 002 Apr 12, 2007 Apr NEWA
>A> AB 5MG;500MG N78083 003 Apr 12, 2007 Apr NEWA
HALOBETASOL PROPIONATE
CREAM; TOPICAL
HALOBETASOL PROPIONATE
>A> AB G AND W LABS 0.05% N78162 001 Apr 24, 2007 Apr NEWA
HISTRELIN ACETATE
IMPLANT; SUBCUTANEOUS
VANTAS
>A> + INDEVUS 50MG N21732 001 Oct 12, 2004 Apr CAHN
>D> + VALERA 50MG N21732 001 Oct 12, 2004 Apr CAHN
HYDROCODONE BITARTRATE; IBUPROFEN
TABLET; ORAL
HYDROCODONE BITARTRATE AND IBUPROFEN
>D> AB + INTERPHARM 5MG;200MG N76642 002 Mar 18, 2004 Apr CRLD
>A> AB 5MG;200MG N76642 002 Mar 18, 2004 Apr CRLD
HYDROMORPHONE HYDROCHLORIDE
INJECTABLE; INJECTION
HYDROMORPHONE HYDROCHLORIDE
>A> AP BARR 10MG/ML N76444 001 Apr 25, 2003 Apr CAHN
>D> AP MAYNE PHARMA 10MG/ML N76444 001 Apr 25, 2003 Apr CAHN
LAPATINIB DITOSYLATE
TABLET; ORAL
TYKERB
>D> + GLAXOSMITHKLINE EQ 250MG BASE N22059 001 Mar 13, 2007 Apr CAHN
>A> + SMITHKLINE EQ 250MG BASE N22059 001 Mar 13, 2007 Apr CAHN
LIDOCAINE; TETRACAINE
CREAM; TOPICAL
LIDOCAINE AND TETRACAINE
>A> + GALDERMA LABS LP 7%;7% N21717 001 Jun 29, 2006 Apr CAHN
>D> + ZARS 7%;7% N21717 001 Jun 29, 2006 Apr CAHN
LIOTHYRONINE SODIUM
INJECTABLE; INJECTION
TRIOSTAT
>D> AP + JONES PHARMA EQ 0.01MG BASE/ML N20105 001 Dec 31, 1991 Apr CAHN
>A> AP + KING PHARMS EQ 0.01MG BASE/ML N20105 001 Dec 31, 1991 Apr CAHN
LISINOPRIL
TABLET; ORAL
LISINOPRIL
>A> AB WOCKHARDT 2.5MG N78402 001 Apr 19, 2007 Apr NEWA
>A> AB 5MG N78402 002 Apr 19, 2007 Apr NEWA
>A> AB 10MG N78402 003 Apr 19, 2007 Apr NEWA
>A> AB 20MG N78402 004 Apr 19, 2007 Apr NEWA
>A> AB 30MG N78402 005 Apr 19, 2007 Apr NEWA
>A> AB 40MG N78402 006 Apr 19, 2007 Apr NEWA
METHOTREXATE SODIUM
INJECTABLE; INJECTION
>D> METHOTREXATE
>D> AP + ABRAXIS PHARM EQ 50MG BASE/2ML (25MG/ML) N40263 001 Feb 26, 1999 Apr CTNA
>D> AP + EQ 250MG BASE/10ML (25MG/ML) N40263 002 Feb 26, 1999 Apr CTNA
>D> AP + MAYNE PHARMA EQ 50MG BASE/2ML (25 MG/ML) N11719 010 Dec 15, 2004 Apr CTNA
METHOTREXATE LPF
>A> @ HOSPIRA EQ 25MG BASE/ML N11719 007 Mar 31, 1982 Apr CAHN
>D> @ MAYNE PHARMA EQ 25MG BASE/ML N11719 007 Mar 31, 1982 Apr CAHN
METHOTREXATE PRESERVATIVE FREE
>A> @ HOSPIRA EQ 20MG BASE/2ML (10 MG/ML) N11719 014 Apr 13, 2005 Apr CAHN
>A> @ EQ 500MG BASE/20ML (25 MG/ML) N11719 013 Apr 13, 2005 Apr CAHN
>A> @ EQ 2.5GM BASE/100ML (25 MG/ML) N11719 011 Apr 13, 2005 Apr CAHN
>D> @ MAYNE PHARMA EQ 20MG BASE/2ML (10 MG/ML) N11719 014 Apr 13, 2005 Apr CAHN
>D> @ EQ 500MG BASE/20ML (25 MG/ML) N11719 013 Apr 13, 2005 Apr CAHN
>D> + EQ 1GM BASE/40ML (25MG/ML) N11719 012 Apr 13, 2005 Apr CAHN
>D> @ EQ 2.5GM BASE/100ML (25 MG/ML) N11719 011 Apr 13, 2005 Apr CAHN
>A> METHOTREXATE SODIUM
>A> AP + ABRAXIS PHARM EQ 50MG BASE/2ML (25MG/ML) N40263 001 Feb 26, 1999 Apr CTNA
>A> AP + EQ 250MG BASE/10ML (25MG/ML) N40263 002 Feb 26, 1999 Apr CTNA
>D> AP + BEDFORD EQ 50MG BASE/2ML (25MG/ML) N89340 001 Sep 16, 1986 Apr CTNA
>D> + EQ 250MG BASE/10ML (25 MG/ML) N89343 001 Sep 16, 1986 Apr CTEC
>A> @ HOSPIRA EQ 2.5MG BASE/ML N11719 004 Apr CAHN
>A> @ EQ 20MG BASE/VIAL N11719 001 Apr CAHN
>A> @ EQ 25MG BASE/ML N11719 005 Apr CAHN
>A> @ EQ 50MG BASE/VIAL N11719 003 Apr CAHN
>A> AP + EQ 50MG BASE/2ML (25 MG/ML) N11719 010 Dec 15, 2004 Apr CTNA
>A> @ EQ 100MG BASE/VIAL N11719 006 Apr CAHN
>D> @ MAYNE PHARMA EQ 2.5MG BASE/ML N11719 004 Apr CAHN
>D> @ EQ 20MG BASE/VIAL N11719 001 Apr CAHN
>D> @ EQ 25MG BASE/ML N11719 005 Apr CAHN
>D> @ EQ 50MG BASE/VIAL N11719 003 Apr CAHN
>D> @ EQ 100MG BASE/VIAL N11719 006 Apr CAHN
>A> METHOTREXATE SODIUM PRESERVATIVE FREE
>A> AP + BEDFORD EQ 50MG BASE/2ML (25MG/ML) N89340 001 Sep 16, 1986 Apr CTNA
>A> AP + EQ 250MG BASE/10ML (25MG/ML) N89343 001 Sep 16, 1986 Apr CTEC
>A> AP + GENERAMEDIX EQ 50MG BASE/2ML (25MG/ML) N40767 001 Apr 30, 2007 Apr NEWA
>A> AP + EQ 250MG BASE/10ML (25MG/ML) N40768 001 Apr 30, 2007 Apr NEWA
>A> AP + EQ 1GM BASE/40ML (25MG/ML) N40716 001 Apr 30, 2007 Apr NEWA
>A> @ HOSPIRA EQ 1GM BASE/VIAL N11719 009 Apr 07, 1988 Apr CAHN
>A> AP + EQ 1GM BASE/40ML (25MG/ML) N11719 012 Apr 13, 2005 Apr CAHN
>D> @ MAYNE PHARMA EQ 1GM BASE/VIAL N11719 009 Apr 07, 1988 Apr CAHN
METHYLPHENIDATE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
CONCERTA
>A> ALZA 18MG N21121 001 Aug 01, 2000 Apr CAHN
>A> 27MG N21121 004 Apr 01, 2002 Apr CAHN
>A> 36MG N21121 002 Aug 01, 2000 Apr CAHN
>A> + 54MG N21121 003 Dec 08, 2000 Apr CAHN
>D> JOHNSON AND 18MG N21121 001 Aug 01, 2000 Apr CAHN
>D> 27MG N21121 004 Apr 01, 2002 Apr CAHN
>D> 36MG N21121 002 Aug 01, 2000 Apr CAHN
>D> + 54MG N21121 003 Dec 08, 2000 Apr CAHN
MEXILETINE HYDROCHLORIDE
CAPSULE; ORAL
MEXILETINE HYDROCHLORIDE
>D> AB TEVA 250MG N74377 003 May 16, 1995 Apr CRLD
>A> AB + 250MG N74377 003 May 16, 1995 Apr CRLD
>D> MEXITIL
>D> AB BOEHRINGER 150MG N18873 002 Dec 30, 1985 Apr DISC
>A> @ 150MG N18873 002 Dec 30, 1985 Apr DISC
>D> AB 200MG N18873 003 Dec 30, 1985 Apr DISC
>A> @ 200MG N18873 003 Dec 30, 1985 Apr DISC
>D> AB + 250MG N18873 004 Dec 30, 1985 Apr DISC
>A> @ 250MG N18873 004 Dec 30, 1985 Apr DISC
MIDAZOLAM HYDROCHLORIDE
INJECTABLE; INJECTION
MIDAZOLAM HYDROCHLORIDE
>D> AP HOSPIRA EQ 1MG BASE/ML N75293 001 Jun 20, 2000 Apr CRLD
>A> AP + EQ 1MG BASE/ML N75293 001 Jun 20, 2000 Apr CRLD
MOMETASONE FUROATE
CREAM; TOPICAL
MOMETASONE FUROATE
>A> AB TOLMAR 0.1% N76591 001 Apr 18, 2007 Apr NEWA
MORPHINE SULFATE
CAPSULE, EXTENDED RELEASE; ORAL
KADIAN
>A> ALPHARMA BRANDED 10MG N20616 008 Apr 20, 2007 Apr NEWA
>A> 20MG N20616 001 Jul 03, 1996 Apr CAHN
>A> BX 30MG N20616 004 Mar 09, 2001 Apr CAHN
>A> 50MG N20616 002 Jul 03, 1996 Apr CAHN
>A> BX 60MG N20616 005 Mar 09, 2001 Apr CAHN
>A> 80MG N20616 006 Oct 27, 2006 Apr CAHN
>A> + 100MG N20616 003 Jul 03, 1996 Apr CAHN
>A> 200MG N20616 007 Feb 27, 2007 Apr CAHN
>D> ALPHARMA US 20MG N20616 001 Jul 03, 1996 Apr CAHN
>D> BX 30MG N20616 004 Mar 09, 2001 Apr CAHN
>D> 50MG N20616 002 Jul 03, 1996 Apr CAHN
>D> BX 60MG N20616 005 Mar 09, 2001 Apr CAHN
>D> 80MG N20616 006 Oct 27, 2006 Apr CAHN
>D> + 100MG N20616 003 Jul 03, 1996 Apr CAHN
>D> 200MG N20616 007 Feb 27, 2007 Apr CAHN
NALBUPHINE HYDROCHLORIDE
INJECTABLE; INJECTION
NALBUPHINE HYDROCHLORIDE
>A> AP BARR 10MG/ML N74471 001 Mar 19, 1998 Apr CAHN
>A> AP 20MG/ML N74471 002 Mar 19, 1998 Apr CAHN
>D> AP MAYNE PHARMA 10MG/ML N74471 001 Mar 19, 1998 Apr CAHN
>D> AP 20MG/ML N74471 002 Mar 19, 1998 Apr CAHN
NAPROXEN SODIUM
TABLET; ORAL
NAPROXEN SODIUM
>A> AB GLENMARK EQ 250MG BASE N78314 001 Apr 27, 2007 Apr NEWA
>A> AB EQ 500MG BASE N78314 002 Apr 27, 2007 Apr NEWA
>A> AB INTERPHARM EQ 250MG BASE N78432 001 Apr 25, 2007 Apr NEWA
>A> AB EQ 500MG BASE N78432 002 Apr 25, 2007 Apr NEWA
NEOMYCIN SULFATE
TABLET; ORAL
NEOMYCIN SULFATE
>D> AB + TEVA 500MG N60304 001 Apr CTEC
>A> AA + 500MG N60304 001 Apr CTEC
>D> AB X GEN PHARMS 500MG N65220 001 Jul 28, 2006 Apr CTEC
>A> AA 500MG N65220 001 Jul 28, 2006 Apr CTEC
NIACIN
TABLET, EXTENDED RELEASE; ORAL
NIASPAN
>D> + ABBOTT 500MG N20381 002 Jul 28, 1997 Apr CRLD
>A> 500MG N20381 002 Jul 28, 1997 Apr CRLD
NIMODIPINE
CAPSULE; ORAL
NIMODIPINE
>A> AB BARR 30MG N77811 001 May 02, 2007 Apr NEWA
>A> AB SUN PHARM INDS 30MG N77067 001 Apr 17, 2007 Apr NEWA
NIMOTOP
>D> + BAYER PHARMS 30MG N18869 001 Dec 28, 1988 Apr CFTG
>A> AB + 30MG N18869 001 Dec 28, 1988 Apr CFTG
PRAVASTATIN SODIUM
TABLET; ORAL
PRAVACHOL
>D> + BRISTOL MYERS 80MG N19898 008 Dec 18, 2001 Apr CFTG
>A> AB + 80MG N19898 008 Dec 18, 2001 Apr CFTG
PRAVASTATIN SODIUM
>A> AB RANBAXY 10MG N76445 001 Apr 23, 2007 Apr NEWA
>A> AB 20MG N76445 002 Apr 23, 2007 Apr NEWA
>A> AB 40MG N76445 003 Apr 23, 2007 Apr NEWA
>A> AB 80MG N76445 004 Apr 23, 2007 Apr NEWA
PROMETHAZINE HYDROCHLORIDE
TABLET; ORAL
PROMETHAZINE HYDROCHLORIDE
>A> AB KVK-TECH INC 12.5MG N40712 002 May 04, 2007 Apr NEWA
QUINIDINE SULFATE
TABLET; ORAL
QUINIDINE SULFATE
>D> AB WATSON LABS 300MG N85583 001 Apr DISC
>A> @ 300MG N85583 001 Apr DISC
RAMIPRIL
TABLET; ORAL
ALTACE
>D> COBALT 1.25MG N22021 001 Feb 27, 2007 Apr CAHN
>D> 2.5MG N22021 002 Feb 27, 2007 Apr CAHN
>D> 5MG N22021 003 Feb 27, 2007 Apr CAHN
>D> + 10MG N22021 004 Feb 27, 2007 Apr CAHN
>A> KING PHARMS 1.25MG N22021 001 Feb 27, 2007 Apr CAHN
>A> 2.5MG N22021 002 Feb 27, 2007 Apr CAHN
>A> 5MG N22021 003 Feb 27, 2007 Apr CAHN
>A> + 10MG N22021 004 Feb 27, 2007 Apr CAHN
>A> RETAPAMULIN
>A> OINTMENT; TOPICAL
>A> ALTABAX
>A> + GLAXO GRP LTD 1% N22055 001 Apr 12, 2007 Apr NEWA
RISEDRONATE SODIUM
TABLET; ORAL
ACTONEL
>A> + PROCTER AND 75MG N20835 004 Apr 16, 2007 Apr NEWA
RISPERIDONE
INJECTABLE; INTRAMUSCULAR
RISPERDAL CONSTA
>A> JANSSEN PHARMA 12.5MG/VIAL N21346 004 Apr 12, 2007 Apr NEWA
SERTRALINE HYDROCHLORIDE
TABLET; ORAL
SERTRALINE HYDROCHLORIDE
>A> AB DR REDDYS LABS EQ 25MG BASE N76442 001 Apr 30, 2007 Apr NEWA
>A> AB EQ 50MG BASE N76442 002 Apr 30, 2007 Apr NEWA
>A> AB EQ 100MG BASE N76442 003 Apr 30, 2007 Apr NEWA
SEVOFLURANE
LIQUID; INHALATION
>A> SOJOURN
>A> AN MINRAD 100% N77867 001 May 02, 2007 Apr NEWA
SODIUM CHLORIDE
INJECTABLE; INJECTION
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>A> AP FRESENIUS MEDCL 900MG/100ML N78177 001 Apr 12, 2007 Apr NEWA
SOMATROPIN RECOMBINANT
INJECTABLE; INJECTION
>A> VALTROPIN
>A> BX LG LIFE 5MG/VIAL N21905 001 Apr 19, 2007 Apr NEWA
SULFANILAMIDE
CREAM; VAGINAL
AVC
>A> + AZUR PHARMA 15% N06530 003 Jan 27, 1987 Apr CAHN
>D> + PHARMELLE 15% N06530 003 Jan 27, 1987 Apr CAHN
SUPPOSITORY; VAGINAL
AVC
>A> @ AZUR PHARMA 1.05GM N06530 004 Jan 27, 1987 Apr CAHN
>D> @ PHARMELLE 1.05GM N06530 004 Jan 27, 1987 Apr CAHN
TADALAFIL
TABLET; ORAL
CIALIS
>A> LILLY 5MG N21368 001 Nov 21, 2003 Apr CAHN
>A> 10MG N21368 002 Nov 21, 2003 Apr CAHN
>A> + 20MG N21368 003 Nov 21, 2003 Apr CAHN
>D> LILLY ICOS 5MG N21368 001 Nov 21, 2003 Apr CAHN
>D> 10MG N21368 002 Nov 21, 2003 Apr CAHN
>D> + 20MG N21368 003 Nov 21, 2003 Apr CAHN
TERBUTALINE SULFATE
TABLET; ORAL
>D> BRETHINE
>D> AB AAIPHARMA LLC 2.5MG N17849 001 Apr DISC
>A> @ 2.5MG N17849 001 Apr DISC
>D> AB + 5MG N17849 002 Apr DISC
>A> @ 5MG N17849 002 Apr DISC
TETRACYCLINE HYDROCHLORIDE
CAPSULE; ORAL
ACHROMYCIN V
>A> @ HERITAGE PHARMS 250MG N50278 003 Apr CAHN
>A> @ 500MG N50278 001 Apr CAHN
>D> @ RADIUS PHARMS 250MG N50278 003 Apr CAHN
>D> @ 500MG N50278 001 Apr CAHN
TRAMADOL HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
ULTRAM ER
>D> BIOVAIL LABS INTL 100MG N21692 001 Sep 08, 2005 Apr CRLD
>A> + 100MG N21692 001 Sep 08, 2005 Apr CRLD
>D> + 300MG N21692 003 Sep 08, 2005 Apr CRLD
>A> 300MG N21692 003 Sep 08, 2005 Apr CRLD
TRIAMCINOLONE ACETONIDE
CREAM; TOPICAL
TRIAMCINOLONE ACETONIDE
>D> AT ALTANA 0.5% N85692 002 Apr CRLD
>A> AT + 0.5% N85692 002 Apr CRLD
VALRUBICIN
SOLUTION; INTRAVESICAL
VALSTAR PRESERVATIVE FREE
>A> + INDEVUS PHARMS 40MG/ML N20892 001 Sep 25, 1998 Apr CAHN
>D> + VALERA 40MG/ML N20892 001 Sep 25, 1998 Apr CAHN
ZOLEDRONIC ACID
INJECTABLE; IV (INFUSION)
>A> RECLAST
>A> + NOVARTIS EQ 5MG BASE/100ML N21817 001 Apr 16, 2007 Apr NEWA
ZOLPIDEM TARTRATE
>A> TABLET, ORALLY DISINTEGRATING; ORAL
>A> TOVALT ODT
>A> BIOVAIL LABS INTL 5MG N21412 001 Apr 25, 2007 Apr NEWA
>A> + 10MG N21412 002 Apr 25, 2007 Apr NEWA
TABLET; ORAL
AMBIEN
>D> SANOFI AVENTIS US 5MG N19908 001 Dec 16, 1992 Apr CFTG
>A> AB 5MG N19908 001 Dec 16, 1992 Apr CFTG
>D> + 10MG N19908 002 Dec 16, 1992 Apr CFTG
>A> AB + 10MG N19908 002 Dec 16, 1992 Apr CFTG
>A> ZOLPIDEM TARTRATE
>A> AB APOTEX INC 5MG N77884 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N77884 002 Apr 23, 2007 Apr NEWA
>A> AB AUROBINDO 5MG N78413 001 May 04, 2007 Apr NEWA
>A> AB 10MG N78413 002 May 04, 2007 Apr NEWA
>A> AB CARACO 5MG N77359 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N77359 002 Apr 23, 2007 Apr NEWA
>A> AB CARLSBAD 5MG N77990 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N77990 002 Apr 23, 2007 Apr NEWA
>A> AB DR REDDYS LABS 5MG N77985 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N77985 002 Apr 23, 2007 Apr NEWA
>A> AB GENPHARM 5MG N78016 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N78016 002 Apr 23, 2007 Apr NEWA
>A> AB LEK PHARMS DD 5MG N77322 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N77322 002 Apr 23, 2007 Apr NEWA
>A> AB MUTUAL PHARMA 5MG N77288 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N77288 002 Apr 23, 2007 Apr NEWA
>A> AB MYLAN 5MG N76578 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N76578 002 Apr 23, 2007 Apr NEWA
>A> AB PAR PHARM 5MG N76062 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N76062 002 Apr 23, 2007 Apr NEWA
>A> AB RANBAXY 5MG N78055 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N78055 002 Apr 23, 2007 Apr NEWA
>A> AB ROXANE 5MG N77214 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N77214 002 Apr 23, 2007 Apr NEWA
>A> AB SYNTHON PHARMS 5MG N77540 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N77540 002 Apr 23, 2007 Apr NEWA
>A> AB TEVA 5MG N76410 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N76410 002 Apr 23, 2007 Apr NEWA
>A> AB WATSON LABS 5MG N77773 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N77773 002 Apr 23, 2007 Apr NEWA
>A> DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN
>A> CAPSULE; ORAL
>A> ADVIL PM
>A> + WYETH CONS 25MG;EQ 200MG FREE ACID AND N21393 001 Dec 21, 2005 Apr CAIN
>D> DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN POTASSIUM
>D> CAPSULE; ORAL
>D> ADVIL PM
>D> + WYETH CONS 25MG;200MG N21393 001 Dec 21, 2005 Apr CAIN
GUAIFENESIN
TABLET, EXTENDED RELEASE; ORAL
>D> HUMABID
>D> + ADAMS RESP 1.2GM N21282 002 Dec 18, 2002 Apr CTNA
>A> HUMIBID
>A> + ADAMS RESP 1.2GM N21282 002 Dec 18, 2002 Apr CTNA
>D> IBUPROFEN POTASSIUM; PSEUDOEPHEDRINE HYDROCHLORIDE
>D> CAPSULE; ORAL
>D> ADVIL COLD AND SINUS
>D> + WYETH CONS 200MG;30MG N21374 001 May 30, 2002 Apr CAIN
>A> IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE
>A> CAPSULE; ORAL
>A> ADVIL COLD AND SINUS
>A> + WYETH CONS EQ 200MG FREE ACID AND N21374 001 May 30, 2002 Apr CAIN
LORATADINE
TABLET, ORALLY DISINTEGRATING; ORAL
>A> LORATADINE REDIDOSE
>A> RANBAXY 10MG N77153 001 Apr 11, 2007 Apr NEWA
Back
to Top
Back to Additions/Deletions Index
Date created: May 9, 2007; updated August 8, 2007 |
|